| Bioactivity | BAY-184 is a selective and orally active KAT6A and KAT6B inhibitor. BAY-184 inhibits KAT6A/KAT6B activity with an IC50 of 71 nM and 83 nM. respectively BAY-184 inhibits ERα transcriptional activity. BAY-184 inhibits proliferation of diverse breast cancer subtypes, and inhibits tumor growth[1]. |
| CAS | 2520347-03-7 |
| Formula | C23H20N2O4S |
| Molar Mass | 420.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ter Laak A, et al. Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor. J Med Chem. 2024 Nov 14;67(21):19282-19303. |
BAY-184
CAS: 2520347-03-7 F: C23H20N2O4S W: 420.48
BAY-184 is a selective and orally active KAT6A and KAT6B inhibitor. BAY-184 inhibits KAT6A/KAT6B activity with an IC50 o
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.